345627-92-1 Usage
General Description
SNS-032 is a synthetic compound that acts as a selective inhibitor of cyclin-dependent kinases (CDKs) 2, 7, and 9, which are key regulators of cell cycle progression and transcription. It has been studied for its potential use as an anti-cancer agent, as it has been shown to inhibit the growth of various cancer cell lines in laboratory studies. SNS-032 has also been investigated for its ability to enhance the effectiveness of other anti-cancer therapies, such as radiation and chemotherapy, by potentiating their effects on cancer cells. Additionally, SNS-032 has shown promise in the treatment of certain inflammatory diseases, such as rheumatoid arthritis, by modulating the production of pro-inflammatory cytokines. Further research is ongoing to fully understand the potential therapeutic applications of SNS-032 and to explore its safety and efficacy in clinical settings.
Check Digit Verification of cas no
The CAS Registry Mumber 345627-92-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,4,5,6,2 and 7 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 345627-92:
(8*3)+(7*4)+(6*5)+(5*6)+(4*2)+(3*7)+(2*9)+(1*2)=161
161 % 10 = 1
So 345627-92-1 is a valid CAS Registry Number.
InChI:InChI=1/2C17H24N4O2S2.C4H6O6/c2*1-17(2,3)12-8-19-13(23-12)10-24-14-9-20-16(25-14)21-15(22)11-4-6-18-7-5-11;5-1(3(7)8)2(6)4(9)10/h2*8-9,11,18H,4-7,10H2,1-3H3,(H,20,21,22);1-2,5-6H,(H,7,8)(H,9,10)/t;;1-,2-/m..1/s1
